Silence Therapeutics reported 23.68M in Operating Expenses for its fiscal quarter ending in September of 2024.


Operating Expenses Change Date
AstraZeneca USD 10.95B 1.04B Jun/2025
Autolus Therapeutics Ltd 82.61M 8.39M Jun/2025
Hikma Pharmaceutical USD 1.31B 63M Dec/2024
Novartis USD 9.97B 1.02B Jun/2025
Roche Holding CHF 11.43B 1.48B Dec/2024
Silence Therapeutics 23.68M 4.76M Sep/2024